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INTRODUCTION AND OBJECTIVES: Some reports suggested
that nephron sparing surgery (NSS) may better protect against other-
cause mortality (OCM) when compared with radical nephrectomy (RN)
in patients with small renal masses. However, the majority of those
studies could not adjust their results for potential selection bias sec-
ondary to clinical baseline characteristics of patients. In the current
study, we aimed to test the effect of treatment type (NSS vs. RN) after
accounting for clinical characteristics, comorbidities and individual car-
diovascular risk.
METHODS: A multi-institutional collaboration among four
European Tertiary Care Centers allowed collecting 2685 patients with
a clinical T1a-T1b N0 M0 renal mass. Patients underwent RN
(n¼1059, 39.4%) or NSS (n¼1626, 60.6%) and showed normal
estimated glomerular filtration rates (eGFR) before surgery (defined
as a pre-operative eGFR60 milliliters per minute per 1.73 m2).
Descriptive, univariable and multivariable Cox regression analyses
were used to predict the risk of OCM. To adjust for inherent baseline
differences among patients, we included as covariates: age, clinical
tumor size, gender, presence of hypertension at diagnosis, baseline
Charlson comorbidity index (CCI), body mass index and smoker
status.
RESULTS: Mean follow up period was 76 months (median 61).
Mean patient age resulted 60 years (median 62). Mean body mass
index resulted 25 kg/m2. Overall, 37.2% and 9.4% of the patients had
hypertension or diabetes, respectively. CCI resulted 0-1 in 73.2% of
the patients.
The 5- and 10-yr OCM rates after nephrectomy were 5.2% and
13.2% for NSS versus 7.4% and 15.1% for RN, respectively (p¼0.3).
At multivariable analyses, patients who underwent PN showed similar
risk to die for OCM compared with their RN-treated counterparts
(hazard ratio [HR]: 0.77; 95% confidence interval, 0.48-1.25; p¼0.3).
Increasing age (HR: 1.12, p<0.001), higher CCI (HR: 1.21, p¼0.04)
and smoker status (HR: 1.94, p¼0.02) resulted independent predictors
of OCM.
CONCLUSIONS: After correcting for clinical characteristics,
comorbidities and cardiovascular risk at diagnosis, NSS does not
decrease other-causes mortality relative to RN in patients with
clinical T1a-T1b renal masses and a normal kidney function before
surgery.
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INTRODUCTION AND OBJECTIVES: Some reports suggested
that nephron sparing surgery (NSS) may protect against renal function
impairment (RFI) when compared with radical nephrectomy (RN) in
patients with small renal masses. In the current study, we aimed to test
the effect of treatment type (NSS vs. RN) on prevalence of RFI and
renal end-stage kidney disease (ESRD) after accounting for clinical
characteristics, comorbidities and individual cardiovascular risk.
METHODS: A multi-institutional collaboration among four Eu-
ropean Tertiary Care Centers allowed collecting 2024 patients with a
clinical T1a-T1b N0 M0 renal mass and complete functional follow-up
data. Patients underwent RN (n¼765, 37.8%) or NSS (n¼1259, 62.2%)
and showed normal estimated glomerular filtration rates (eGFR) before
surgery (defined as a pre-operative eGFR60 ml/min/1.73 m2). Uni-
variable and multivariable Cox regression analyses predicting RFI were
performed. To adjust for inherent baseline differences among patients,
we included as covariates: preoperative creatinine, age, clinical tumor
size, gender, presence of hypertension or diabetes at diagnosis,
baseline Charlson comorbidity index (CCI), body mass index and
smoker status.
RESULTS: At a mean follow up period of 68.2 months, 81.1%
vs. 55.8% patients showed normal renal function after NSS vs. RN,
respectively (p<0.001). The prevalence of mild RFI, severe RFI and
ESRD resulted 25.3, 1.0% and 2.1%. However, after stratifying for
treatment type, the prevalence of mild RFI, severe RFI and ESRD
resulted higher in the group of patients treated with RN relative to NSS
(39.7 vs. 16.6%, 1.4 vs. 0.8% and 3.0 vs. 1.5%, respectively, p<0.001).
At multivariable analyses, patients who underwent PN showed signifi-
cantly lower risk to harbour RFI compared with their RN-treated coun-
terparts (hazard ratio [HR]: 0.63; 95% confidence interval, 0.44-0.89;
p¼0.008). Increasing age (HR: 1.06, p<0.001), larger tumors (HR: 1.04,
p<0.001), presence of hypertension (HR: 5.39, p¼0.006) and presence
of diabetes (HR: 1.56, p¼0.05) resulted independent predictors of RFI.
CONCLUSIONS: Although the risk of severe renal function
impairment and ESRD is negligible, up to 30% of the patients with
clinical T1a-T1b renal masses and a normal preoperative kidney func-
tion harbour mild RFI after surgery. Also after accounting for clinical
characteristics, comorbidities and cardiovascular risk at diagnosis, NSS
significantly decrease the risk of RFI relative to RN.
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INTRODUCTION AND OBJECTIVES: Vascular targeted
photodynamic therapy (VTP) with WST-11 is a focal therapy modality
with many potential advantages over existing thermal and non-thermal
